Literature DB >> 8829273

Renal transplantation in the older end stage renal disease patient.

B N Becker1, N Ismail, Y T Becker, R C MacDonnell, J H Helderman.   

Abstract

Transplant physicians in the United States continue to face an interesting problem when offering kidney transplantation as a form of renal replacement therapy to older end-stage renal disease (ESRD) patients. The limited life-expectancy of these patients and an ever-present shortage of cadaveric organs makes kidney transplantation in this population a potentially controversial issue. Early results suggested poor outcomes for cadaveric renal transplantation in middle-aged or elderly ESRD patients. Improved patient selection, changes in immunosuppression regimens, and living-related transplantation have increased the success of transplantation in these patients. Efforts to define older patients at risk for cardiovascular disease and to account for their altered immune function may further improve outcomes. However, if older ESRD patients are to be rightfully included in the patient population eligible for transplantation, then the organ shortage will inevitably worsen. A potentially intriguing solution to this problem is to expand the donor pool by including older donors. Despite data suggesting that recipients of older grafts may have shorter graft survival; older donors could readily serve as a source of kidneys for older recipients who do not require 20+ year graft survival based upon their projected lifespan. Ultimately, age alone should not serve as a contraindication to renal transplantation. In patients over the age of 60, 1-year patient and graft survival rates approach 85% and 75%, respectively. However, careful assessment of "biologic" age and comorbid illnesses should be considered when offering renal transplantation to older patients.

Entities:  

Mesh:

Year:  1996        PMID: 8829273

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  6 in total

1.  Renal transplantation in the elderly--the Irish experience.

Authors:  L Giblin; M Hollander; D Little; D Hickey; J Donohoe; J J Walshe; A Dorman; P O'Kelly; P J Conlon
Journal:  Ir J Med Sci       Date:  2005 Apr-Jun       Impact factor: 1.568

Review 2.  Renal transplantation in the elderly.

Authors:  J S Cameron
Journal:  Int Urol Nephrol       Date:  2000       Impact factor: 2.370

Review 3.  Renal transplantation in patients above 60 years of age in the modern era: a single center experience with a review of the literature.

Authors:  A Basu; S M Greenstein; S Clemetson; M Malli; D Kim; R Schechner; P Gerst; V A Tellis
Journal:  Int Urol Nephrol       Date:  2000       Impact factor: 2.370

Review 4.  Pharmacokinetic considerations relating to tacrolimus dosing in the elderly.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

5.  Acute rejection in the elderly recipient: influence of age in the outcome of kidney transplantation.

Authors:  Rosa Palomar; Juan C Ruiz; José A Zubimendi; Julio G Cotorruelo; Angel L M de Francisco; Emilio Rodrigo; Saturnino Sanz; Gema Fernández-Fresnedo; Manuel Arias
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 6.  Drug therapy in transplant recipients: special considerations in the elderly with comorbid conditions.

Authors:  José F Bernardo; Jerry McCauley
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.